(Q38095550)

28 August 2017

title

Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs (English)

1 reference

28 August 2017

main subject

knowledge gap hypothesis

1 reference

1 reference

poliovirus

1 reference

2

Mark A Pallansch

1 reference

Radboud J Duintjer Tebbens

28 August 2017

1

object named as

Radboud J Duintjer Tebbens

1 reference

28 August 2017

9

Roland W Sutter

1 reference

28 August 2017

4

Neal A Halsey

1 reference

28 August 2017

12

Stephen L Cochi

1 reference

28 August 2017

11

Steven G F Wassilak

1 reference

28 August 2017

14

Kimberly M Thompson

1 reference

28 August 2017

author name string

Konstantin M Chumakov

3

1 reference

28 August 2017

Tapani Hovi

5

1 reference

28 August 2017

Philip D Minor

6

1 reference

28 August 2017

John F Modlin

7

1 reference

28 August 2017

Peter A Patriarca

8

1 reference

28 August 2017

Peter F Wright

10

1 reference

28 August 2017

Jong-Hoon Kim

13

1 reference

28 August 2017

publication date

28 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

33

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

606-646

1 reference

Preeradication vaccine policy options for poliovirus infection and disease control.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Herd immunity: history, theory, practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

The influence of natural and artificially induced immunity on alimentary infections with polioviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Optimal vaccine stockpile design for an eradicated disease: application to polio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Evaluation of response scenarios to potential polio outbreaks using mathematical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Eradication versus control for poliomyelitis: an economic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Deterministic models for the eradication of poliomyelitis: vaccination with the inactivated (IPV) and attenuated (OPV) polio virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Expert review on poliovirus immunity and transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Expert judgment-based risk assessment using statistical scenario analysis: a case study-running the bulls in Pamplona (Spain).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

A structured expert judgment study for a model of Campylobacter transmission during broiler-chicken processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Expert judgment in risk analysis and management: process, context, and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

A delphi method expert survey to derive standards for flood damage data collection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

From emergence to eradication: the epidemiology of poliomyelitis deconstructed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Polio immunity to killed vaccine: an 18-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Vaccination against polio should not be stopped

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

Uncertainty and sensitivity analyses of a dynamic economic evaluation model for vaccination programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12031

The molecular biology of poliovaccines

21 January 2018

1 reference

12 December 2020

Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine

1 reference

12 December 2020

Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1

1 reference

12 December 2020

Elimination of Poliomyelitis in Finland

1 reference

12 December 2020

Some observations on poliomyelitis lameness surveys.

1 reference

12 December 2020

Viral vaccination via the mucosal routes.

1 reference

12 December 2020

The elimination of polio in the Scandinavian countries

1 reference

12 December 2020

THE RESPONSE AND THE LACK OF SPREAD IN SWEDISH SCHOOL CHILDREN GIVEN AN ATTENUATED POLIOVIRUS VACCINE PREPARED IN A HUMAN DIPLOID CELL STRAIN

1 reference

12 December 2020

Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville. Belgian Congo. 2. Studies of the safety and efficacy of vaccination

1 reference

12 December 2020

Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children. A family study during a type 1 poliomyelitis epidemic

1 reference

12 December 2020

Policy decision options during the first 5 years following certification of polio eradication

1 reference

12 December 2020

Policy. OPV cessation--the final step to a "polio-free" world

1 reference

12 December 2020

The risks, costs, and benefits of possible future global policies for managing polioviruses

1 reference

12 December 2020

Uncertainty and sensitivity analyses of a decision analytic model for posteradication polio risk management

1 reference

12 December 2020

The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation.

1 reference

12 December 2020

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

1 reference

12 December 2020

Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials

1 reference

12 December 2020

Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response

1 reference

12 December 2020

The probability of undetected wild poliovirus circulation after apparent global interruption of transmission

1 reference

12 December 2020

Identifiers

DOI

10.1111/RISA.12031

1 reference

28 August 2017

0 references

1 reference